financetom
Business
financetom
/
Business
/
Palantir Technologies Insider Sold Shares Worth $69,269,088, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palantir Technologies Insider Sold Shares Worth $69,269,088, According to a Recent SEC Filing
Feb 25, 2025 12:42 AM

03:21 AM EST, 02/25/2025 (MT Newswires) -- Stephen Andrew Cohen, Director, President and Secretary, on February 20, 2025, sold 675,000 shares in Palantir Technologies ( PLTR ) for $69,269,088. Following the Form 4 filing with the SEC, Cohen has control over a total of 592 Class A common shares of the company, with 592 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1321655/000132165525000026/xslF345X05/wk-form4_1740447420.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Samsung fourth-quarter profit growth slows as chip issues weigh
Samsung fourth-quarter profit growth slows as chip issues weigh
Jan 30, 2025
SEOUL (Reuters) -Samsung Electronics ( SSNLF ) reported fourth-quarter profit that rose 130% from a low base, confirming it had missed earlier estimates due to slowing memory chip demand and extra costs as it works towards providing high-end chips to Nvidia ( NVDA ). Samsung said that in the first quarter of 2025, overall earnings improvement may be limited due...
Weight-loss drug developer Metsera raises $275 million in US IPO
Weight-loss drug developer Metsera raises $275 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company said on Thursday. ...
Biotech firm Maze Therapeutics raises $140 million in US IPO
Biotech firm Maze Therapeutics raises $140 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech listing this year. Maze priced the offering at $16 per share, within its indicated range of $15 to $17. ...
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Jan 30, 2025
Jan 30 (Reuters) - U.S. insurer Nationwide said on Thursday that it would acquire property and casualty insurer Allstate Corp's ( ALL ) employer stop-loss segment in a $1.25 billion deal, as it seeks to expand its stop-loss insurance offering. The transaction is expected to close in the second half of 2025, Nationwide said in a statement. Stop-loss insurance serves...
Copyright 2023-2026 - www.financetom.com All Rights Reserved